Waters Corp
WAT · Healthcare · Life Sciences Tools & Services
Updated 25 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #281 of 500 by Iconic Score · #34 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Waters Corporation (WAT) is a leading global provider of analytical instruments and software used in laboratories across the life sciences sector, particularly in pharmaceuticals, biotechnology, and environmental testing. With a market capitalization of $35.9 billion, Waters specializes in chromatography, mass spectrometry, and thermal analysis, enabling researchers to enhance the efficiency and accuracy of their analytical processes. The company holds a strong market position, driven by its commitment to innovation, high-quality products, and customer-centric solutions, which are essential for advancing scientific research and ensuring regulatory compliance. Waters' technologies play a critical role in drug development and quality control, making it a key player in the healthcare landscape, where reliable data and insights are vital for improving patient outcomes and advancing public health.
IconicOracleAI™ Brief
Waters Corp's Iconic Score of 48 reflects a mixed brand perception amid recent developments. The company's visibility remains strong with a brand-visibility signal of 75, bolstered by initiatives like the AI-enabled LC-MS workflows and collaboration with Quest Diagnostics on HPV screening. However, concerns about overvaluation based on cash flow estimates have tempered sentiment, contributing to a score that indicates room for improvement in brand strength and market confidence.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.